Home
First Polish drug target programme selected
A drug discovery programme involving an epigenetic target is the first drug target programme from Poland selected by the European Lead Factory. The selected drug target is a part of the oncology project developed by Selvita within its epigenetics platform.
“The goal of this project is to discover new molecules within a specific genomic context that will enable more effective treatment of cancer, at the same time exhibiting fewer side effects than most of current oncology therapies do” – said Dr Krzysztof Brzozka, Chief Scientific Officer at Selvita.
Read the news on Selvita’s website.